Identification of genes differentially expressed in mouse fetuses from streptozotocin-induced diabetic pregnancy by cDNA subtraction

Endocrine Journal

Volumn 55, Issue 2, 2008, Pages 317-323

  Sato, Nanako ^a,b   Sugimura, Yoshihisa ^a,b   Hayashi, Yoshitaka ^a   Murase, Takashi ^a   Kanou, Yasuhiko ^a   Kikkawa, Fumitaka ^b   Murata, Yoshiharu ^a  

^a NAGOYA UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

cDNA subtraction; Congenital malformation; Embryonic development; Gene expression profile; Neural tube defect

Indexed keywords

COMPLEMENTARY DNA; EPHRIN A5; TRANSCRIPTION FACTOR SOX10;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ARTICLE; BRCC3 GENE; COMMD3 GENE; CONTROLLED STUDY; DDX1 GENE; DEVELOPMENTAL STAGE; EMBRYO DEVELOPMENT; EPHRINA5 GENE; FEMALE; FETUS MALFORMATION; FOLBP1 GENE; GENE; GENE CLUSTER; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENETIC ANALYSIS; MOUSE; NEURAL TUBE DEFECT; NONHUMAN; PREGNANCY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SET GENE; SOX10 GENE; STREPTOZOCIN DIABETES;

ANIMALS; CLUSTER ANALYSIS; DIABETES MELLITUS, EXPERIMENTAL; DNA-BINDING PROTEINS; EPHRIN-A5; FEMALE; FETAL DEVELOPMENT; FETUS; GENE EXPRESSION PROFILING; HIGH MOBILITY GROUP PROTEINS; MICE; MICE, INBRED ICR; NEURAL TUBE DEFECTS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREGNANCY; PREGNANCY IN DIABETICS; PREGNANCY, ANIMAL; STREPTOZOCIN; TRANSCRIPTION FACTORS;

EID: 43449139183     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K07-117     Document Type: Article

References (24)

1. Miller E, Hare JW, Cloherty JP, Dunn PJ, Gleason RE, Soeldner JS, Kitzmiller JL (1981) Elevated maternal hemoglobin A1c in early pregnancy and major congenital anomalies in infants of diabetic mothers. N Engl J Med 304: 1331-1334.
2. Eriksson UJ, Cederberg J, Wentzel P (2003) Congenital malformations in offspring of diabetic mothers - animal and human studies. Rev Endocr Metab Disord 4: 79-93.
3. Suhonen L, Hiilesmaa V, Teramo K (2000) Glycaemic control during early pregnancy and fetal malformations in women with type I diabetes mellitus. Diabetologia 43: 79-82.
4. Sheffield JS, Butler-Koster EL, Casey BM, McIntire DD, Leveno KJ (2002) Maternal diabetes mellitus and infant malformations. Obstet Gynecol 100: 925-930.
5. Evers IM, de Valk HW, Visser GH (2004) Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands. BMJ 328: 915.
6. Wentzel P, Thunberg L, Eriksson UJ (1997) Teratogenic effect of diabetic serum is prevented by supplementation of superoxide dismutase and N-acetylcysteine in rat embryo culture. Diabetologia 40: 7-14.
7. Phelan SA, Ito M, Loeken MR (1997) Neural tube defects in embryos of diabetic mice: role of the Pax-3 gene and apoptosis. Diabetes 46: 1189-1197.
8. Loeken MR (2005) Current perspectives on the causes of neural tube defects resulting from diabetic pregnancy. Am J Med Genet C Semin Med Genet 135: 77-87.
9. Copp AJ (2005) Neurulation in the cranial region - normal and abnormal. J Anat 207: 623-635.
10. Greene ND, Copp AJ (2005) Mouse models of neural tube defects: investigating preventive mechanisms. Am J Med Genet C Semin Med Genet 135: 31-41.
11. Li R, Chase M, Jung SK, Smith PJ, Loeken MR (2005) Hypoxic stress in diabetic pregnancy contributes to impaired embryo gene expression and defective development by inducing oxidative stress. Am J Physiol Endocrinol Metab 289: E591-599.
12. Wentzel P, Gareskog M, Eriksson UJ (2005) Folic acid supplementation diminishes diabetes- and glucose-induced dysmorphogenesis in rat embryos in vivo and in vitro. Diabetes 54: 546-553.
13. Diatchenko L, Lau YF, Campbell AP, Chenchik A, Moqadam F, Huang B, Lukyanov S, Lukyanov K, Gurskaya N, Sverdlov ED, Siebert PD (1996) Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc Natl Acad Sci USA 93: 6025-6030.
14. Futaki S, Hayashi Y, Yamashita M, Yagi K, Bono H, Hayashizaki Y, Okazaki Y, Sekiguchi K (2003) Molecular basis of constitutive production of basement membrane components. Gene expression profiles of Engelbreth-Holm-Swarm tumor and F9 embryonal carcinoma cells. J Biol Chem 278: 50691-50701.
15. Fan Z, Beresford PJ, Oh DY, Zhang D, Lieberman J (2003) Tumor suppressor NM23-H1 is a granzyme A-activated DNase during CTL-mediated apoptosis, and the nucleosome assembly protein SET is its inhibitor. Cell 112: 659-672.
16. Godbout R, Packer M, Bie W (1998) Overexpression of a DEAD box protein (DDX1) in neuroblastoma and retinoblastoma cell lines. J Biol Chem 273: 21161-21168.
17. Burstein E, Hoberg JE, Wilkinson AS, Rumble JM, Csomos RA, Komarck CM, Maine GN, Wilkinson JC, Mayo MW, Duckett CS (2005) COMMD proteins, a novel family of structural and functional homologs of MURR1. J Biol Chem 280: 22222-22232.
18. Boudreau HE, Broustas CG, Gokhale PC, Kumar D, Mewani RR, Rone JD, Haddad BR, Kasid U (2007) Expression of BRCC3, a novel cell cycle regulated molecule, is associated with increased phospho-ERK and cell proliferation. Int J Mol Med 19: 29-39.
19. Farmer H, McCabe N, Lord CJ, Tutt AN, Johnson DA, Richardson TB, Santarosa M, Dillon KJ, Hickson I, Knights C, Martin NM, Jackson SP, Smith GC, Ashworth A (2005) Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 434: 917-921.
20. Chen HC, Lin WC, Tsay YG, Lee SC, Chang CJ (2002) An RNA helicase, DDX1, interacting with poly(A) RNA and heterogeneous nuclear ribonucleoprotein K. J Biol Chem 277: 40403-40409.
21. Holmberg J, Clarke DL, Frisen J (2000) Regulation of repulsion versus adhesion by different splice forms of an Eph receptor. Nature 408: 203-206.
22. Piedrahita JA, Oetama B, Bennett GD, van Waes J, Kamen BA, Richardson J, Lacey SW, Anderson RG, Finnell RH (1999) Mice lacking the folic acid-binding protein Folbp1 are defective in early embryonic development. Nat Genet 23: 228-232.
23. Pingault V, Bondurand N, Kuhlbrodt K, Goerich DE, Prehu MO, Puliti A, Herbarth B, Hermans-Borgmeyer I, Legius E, Matthijs G, Amiel J, Lyonnet S, Ceccherini I, Romeo G, Smith JC, Read AP, Wegner M, Goossens M (1998) SOX10 mutations in patients with Waardenburg-Hirschsprung disease. Nat Genet 18: 171-173.
24. Bondurand N, Pingault V, Goerich DE, Lemort N, Sock E, Le Caignec C, Wegner M, Goossens M (2000) Interaction among SOX10, PAX3 and MITF, three genes altered in Waardenburg syndrome. Hum Mol Genet 9: 1907-1917.